NEW YORK, September 28, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: Acorda Therapeutics, Inc. (NASDAQ: ACOR),
Endocyte, Inc. (NASDAQ: ECYT), Cardiovascular Systems,
Inc. (NASDAQ: CSII), Chimerix, Inc. (NASDAQ: CMRX), and
Curis, Inc. (NASDAQ: CRIS). On Friday, September 25, 2015, Nasdaq ended at
4,686.50, down 1.01%, Dow Jones advanced 0.70% to finish the day at
16,314.67, and the S&P closed at 1,931.34, down 0.05%. Register
for your complimentary reports at the links given below.
--
Acorda Therapeutics Inc.
--
Acorda Therapeutics Inc.'s stock edged lower by 5.79% to close
Friday's session at USD 27.83. The
company's shares oscillated between USD
27.06 and USD 29.68, marking a new 52-week low during the
session. The stock recorded a trading volume of 0.65 million
shares, which was above its 50-day daily average volume of 0.60
million shares. Over the last three days Acorda Therapeutics Inc.'s
shares have declined by 7.20% and in the past one week the stock
has moved down 13.52%. Further, the stock is trading at a price to
earnings ratio of 115.96 and price to book ratio of 2.13. This
compares to a historical PE ratio of 98.39 and historical PB ratio
of 3.17. Additionally, the stock is trading at a price to cash flow
ratio of 15.59 and price to sales ratio of 2.73. Sign up and read
the free notes on ACOR at:
http://www.aciassociation.com/ACOR.pdf
--
Endocyte Inc.
--
The stock of Endocyte Inc. lost 4.27% to close Friday's session
at USD 4.93. The shares of the
company moved in the range of USD
4.81 and USD 5.30. A trading
volume of 0.64 million shares was recorded, which was greater than
its 150-day daily average volume of 0.37 million shares. Over the
last five days Endocyte Inc.'s shares have declined by 11.49% while
in the past one month the stock has gained a momentum of 2.07%. The
company has returned 2.07% in the past one month, on a compounded
total return basis. Further, the stock is trading at a price to
book ratio of 1.10 and historical PB ratio of 1.28. Register for
free on ACI Association and access the latest research on ECYT at:
http://www.aciassociation.com/ECYT.pdf
--
Cardiovascular Systems Inc.
--
Cardiovascular Systems Inc.'s stock decreased by 8.47% to close
Friday's session at USD 17.93. The
company's shares fluctuated in the range of USD 17.51 and USD
19.97, touching a new 52-week low during the session. A
total of 0.62 million shares exchanged hands, which surpassed its
52-week average volume of 0.29 million shares. Over the last three
days Cardiovascular Systems Inc.'s shares have declined by 12.24%
and in the past one week the stock has moved down 15.66%. The stock
is trading at a price to book ratio of 4.10 and historical PB ratio
of 6.05. Additionally, the stock is trading at a price to sales
ratio of 3.21. The complete research on CSII is available for free
at: http://www.aciassociation.com/CSII.pdf
--
Chimerix Inc.
--
Chimerix Inc.'s stock slipped by 5.65% to close Friday's session
at USD 42.74. The company's shares
oscillated between USD 40.74 and USD
46.22. The stock recorded a trading volume of 0.54 million
shares, which was above its 50-day daily average volume of 0.41
million shares. Over the last five days Chimerix Inc.'s shares have
declined by 16.86% and in the past one month the stock has lost
7.63%. In addition, over the last three months the stock has lost
7.63% while year to date the shares have picked up 6.16%. The
company has returned 47.13% in the past one year, on a compounded
total return basis. Free in-depth research on CMRX is available at:
http://www.aciassociation.com/CMRX.pdf
--
Curis Inc.
--
Curis Inc.'s stock declined 9.76% to close Friday's session at
USD 2.22. The share price vacillated
between USD 2.13 and USD 2.53. The
stock recorded a trading volume of 0.50 million shares, which was
below its 52-week average volume of 0.85 million shares. Over the
last three days Curis Inc.'s shares have declined by 11.55% and in
the past one week the stock has moved down 13.95%. Moreover, the
shares have picked up 48.00% year to date. On a compounded total
return basis, the company has returned 58.57% in the past one year.
The stock is trading at a price to book ratio of 3.54 and
historical PB ratio of 4.39. The complimentary notes on CRI Scan be
downloaded in PDF format at:
http://www.aciassociation.com/CRIS.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein. The information in this release has been sourced
from a third party data base.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com